Reven Pharmaceuticals Stock
Reven Pharmaceuticals is a startup developing solutions for the treatment of cardiovascular and circulatory-related conditions.
About Reven Pharmaceuticals Stock
Reven Pharmaceuticals, Inc. is a development-stage bio-pharmaceutical company that develops and markets propriety solutions for the treatment of cardiovascular and circulatory related conditions. These non-surgical, minimally invasive treatments have shown to improve vascular function and circulation without invasive medical procedures, such as atherectomy or balloon angioplasty and stents.
Vice President, Regulatory and Quality Affairs
Co-Founder and Chief Executive Officer
Michael K. Handley
Vice President of Operations
Mariëtte Luïse Van Wyk